Living donor transplantation is the preferred treatment for end-stage kidney disease (ESKD).
While living donor transplantation generally substantially enhances the quality of life and …

Better outcomes for living donor transplantation, together with the shortened waiting time
and the increasing gap between supply and demand for kidneys for transplantation, has led …

Abstract Purpose of Review To provide a comprehensive update on the role of genetic
testing for the evaluation of kidney transplant recipient and living donor candidates. Recent …

Living kidney donors (LKDs) with a family history of renal disease are at risk of kidney
disease as compared to LKDs without such history suggesting that some LKDs may be pre …

Living donor kidney transplantation is an effective strategy to mitigate the challenges of solid
organ shortage. However, being a living kidney donor is not without risk, as donors may …

Related living kidney donors (LKDs) are at higher risk of end-stage renal disease (ESRD)
compared with unrelated LKDs. A genetic panel was developed to screen 115 genes …

A genetic basis has been suggested for increased ESKD risks in living kidney donors who
are closely related to their recipients, in Black living donors compared to nonblacks, and in …

The growing accessibility and falling costs of genetic sequencing techniques has expanded
the utilization of genetic testing in clinical practice. For living kidney donation, genetic …

Background: End stage renal disease (ESRD) is a prevalent condition with tendency for
familial clustering. Living kidney donor transplantation is a superior treatment option …

Living donor kidney transplantation benefits the recipient. However, kidney failure can occur
in a small fraction of donors—the risk is not uniform but varies according to donor …